TRAC team grows again

Cornwall-based regulatory affairs specialist appoints three new members of staff

Natalie Grogan, Debbie Finlay and Mike May have joined Cornwall's TRAC, which works with pharmaceutical companies to ensure that they are meeting their regulatory responsibilities.

Grogan takes the role of marketing manager, having relocated from Manchester where she has spent the last seven years in the marketing department of fashion and footwear home retailer JD Williams & Co.

Finlay and May boost TRAC’s Regulatory Affairs team, where they will be working on a range of projects for clients across Europe.

After spending 12 years living and working in Boston, US, Finlay returned to Cornwall in 2005 and graduated with a degree in Biological Science in 2009.

May graduated from Indiana State University in 2007 before relocating to study at the University of Plymouth where he gained a BSc in Human Biosciences.

‘We are delighted to have secured the services of Natalie, Debbie and Mike in the latest part of our development programme. They bring not only experience but also enthusiasm and a real desire to be part of the TRAC success story,’ said TRAC director Sarah Trethowan.

You may also like

Regulatory

Grifols gets nod from European Medicines Agency for entire value chain of Grifols Egypt

The institution's certification endorses the entire plasma value chain under the highest European standards and opens the door for Egypt to, once domestic needs are met, export to other markets including Europe
Regulatory

Regulating innovation: a new focus on digital mental health technologies (DMHTs)

IMed Consultancy’s Benjamin Austin provides a clear understanding of how digital mental health technologies are innovating care and describes the evolving regulatory frameworks that ensure their safety and effectiveness
Regulatory

ten23 health QC lab to support commercial product testing for US customer following FDA approvals

This pivotal regulatory milestone enables FDA-compliant release and stability testing for injectable drug products throughout the clinical and commercial phases, in addition to manufacturing the commercial product
Regulatory

FDA considers black box warning for COVID-19 vaccines amid internal disputes

The US FDA is reportedly weighing a black box warning for COVID-19 vaccines — a move that has alarmed public health leaders and vaccine manufacturers, who say no new safety signals support such action
Regulatory

BIOSECURE Act on track to curb Chinese biotech investment in the US

The amended Act was included in the annual defence bill after failing to pass muster in the last key defence spending bill, but has some notable omissions
Regulatory

One in four European pharma companies at risk of regulatory breaches according to NSF research

The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten
Manufacturing

Autopack launches modular semi-automatic bucket line

Flexible system helps manufacturers improve efficiency and reduce costs
Subscribe now